Skip to NavigationSkip to content

Pharmafile - Manufacturing and Production News

Sandoz, a division of Swiss pharma giant Novartis, has revealed that two of its biosimilars – Rixathon (biosimilar rituximab) and Erelzi (...
According to the patient records that have been examined so far, at least 1,700 may have been put at risk by the recent blunder that saw NHS...
UK patients will be given access to Santhera Pharmaceutical’s Duchene Muscular Dystrophy drug, Raxone (idebenone), through the Early Access to...
Featuring an exclusive NHS interview on the recent cyber attack and the full story on the new Brexit Health Alliance, as well as features on patient...
A study into an injectable form of buprenorphine treatment for opioid abuse has found that the formulation is able to supress symptoms of opioid...
European approval for Novartis' biosimilar version of a Roche blockbuster and a 100-year old Alzheimer's theory is confirmed. Check out the week's...
More drama in the Indian pharma sector as the FDA announces it has enforced a ban on the import of drug products manufactured at three sites owned...
Novartis has achieved positive feedback from its two Phase 3 studies into its eye drug RTH258 (brolucizumab), which found it as effective as its...
Luke Miels left AZ in January to join GSK as the firm’s President of Global Pharmaceuticals, only to face a lawsuit from his former employer over...
After positive results for a ‘vaccine’ to combat fatty deposits in the arteries in mice, the researchers have taken the trial forward into Phase 1...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches